Cancer Immunotherapy Drug Discovery Outsourcing Market - Global Industry Analysis

Cancer Immunotherapy Drug Discovery Outsourcing Market

Cancer Immunotherapy Drug Discovery Outsourcing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Category: Medical Device Report Format : PDF Report Code: ZMR-6012 Status : Upcoming

Cancer Immunotherapy Drug Discovery Out Market

Description

Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Overview

Cancer immunotherapy drug discovery outsourcing refers to the outsourcing of research activities that assist in optimizing the time and funds involved in the process of drug discovery. It is done for various types of cancer like breast cancer, lung cancer, melanoma, colorectal cancer, prostate cancer, ovarian & pancreatic cancer, and head & neck cancer.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Growth Factors

One of the major factors driving the global cancer immunotherapy drug discovery outsourcing market is the growing awareness regarding the advancements in cancer treatment therapies along with the growing investments by prominent pharmaceutical companies to outsource the various activities involved in the process of drug discovery for cancer treatments. Pharmaceutical companies are shifting their focus to immunotherapies as they are vital alternatives for the treatment of cancer due to their high ability to lower the potential risk of tumor recurrence post-chemotherapy. The outsourcing process of research activities reduces the time involved in the process and does help in optimizing the funds for better outcome of investment. The growing research and development activities to innovate novel drugs for the effective treatments of cancer are further fuelling the growth of the global cancer immunotherapy drug discovery outsourcing market. Moreover, the introduction of advanced therapeutic options like HDAC inhibitors, oncolytic viral therapies, cancer vaccines, and monoclonal antibodies is likely to positively shape the trajectory of the global cancer immunotherapy drug discovery outsourcing market.

Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Segmentation

The global cancer immunotherapy drug discovery outsourcing market can be segmented into cancer type, service, drug, and region.

By cancer type, the market can be segmented into pancreatic, ovarian, head & neck, prostate, melanoma, colorectal, breast, and lung. Lung cancer accounts for the largest share in the global market. The delayed diagnosis of lung cancer makes chemotherapy inefficient and this underlying drawback can be overcome with the help of immunotherapy. Immunotherapy is proven to be very effective in the treatment of non-small cell lung cancer. Moreover, the wide availability of immunotherapy is further propelling the growth of the segment. The ovarian segment is anticipated to grow vigorously during the forecast period due to the increasing research and development activities along with the rising prevalence of ovarian cancer all across the globe.

By service, the market can be segmented into cell-based assays, lead screening & characterization, and target identification & validation. The target identification & validation segment holds the largest share in the global cancer immunotherapy drug discovery outsourcing market. The growth can be attributed to the launch of novel drugs constantly in the market for the treatment of cancer patients.

By drug, the market can be segmented into oncolytic viral therapies and cancer vaccines immunomodulators, monoclonal antibodies, and others. The monoclonal antibodies segment holds hegemony over others in the global market.

Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Regional analysis

North America accounts for the largest share in the global cancer immunotherapy drug discovery outsourcing market due to the presence of prominent market players, biotech, and big pharmaceutical companies in the region. Moreover, the growing demand for novel drugs to treat cancer therapy cancer patients along with the growing outsourcing trend in the region will also boost market growth.

Asia Pacific accounts for the second-largest share in the global market due to the introduction of advanced immunotherapy drugs in growing economies like Japan and China to treat cancer patients.

Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Competitive Players

Some of the significant players in the global cancer immunotherapy drug discovery outsourcing market are Molecular Imaging, Inc., STC Biologics, Personalis, Inc., ImmunXperts SA, Celentyx Ltd., DiscoverX Corporation, Genscript Biotech Corporation, BPS Bioscience, Inc, Biosciences Co., Ltd., DiscoverX Corporation, Genscript Biotech Corporation, BPS Bioscience, Inc., HD Biosciences Co., Ltd., Promega Corporation, Crown Bioscience, Inc., Horizon Discovery Group PLC, Aquila BioMedical, Explicyte, and Covance, Inc.

Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

  • zion payment modes

FrequentlyAsked Questions

One of the major factors driving the global cancer immunotherapy drug discovery outsourcing market is the growing awareness regarding the advancements in cancer treatment therapies along with the growing investments by prominent pharmaceutical companies to outsource the various activities involved in the process of drug discovery for cancer treatments. Pharmaceutical companies are shifting their focus to immunotherapies as they are vital alternatives for the treatment of cancer due to their high ability to lower the potential risk of tumor recurrence, post-chemotherapy.

 

Some of the significant players in the global cancer immunotherapy drug discovery outsourcing market are Molecular Imaging, Inc., STC Biologics, Personalis, Inc., ImmunXperts SA, Celentyx Ltd., DiscoverX Corporation, Genscript Biotech Corporation, BPS Bioscience, Inc, and Biosciences Co., Ltd.

North America accounts for the largest share in the global cancer immunotherapy drug discovery outsourcing market due to the presence of prominent market players, biotech, and big pharmaceutical companies in the region.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed